Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Conference committee debates 340B transparency reporting in Senate Bill 2370
Summary
Lawmakers at a conference committee hearing discussed proposed reporting requirements tied to the federal 340B drug discount program in Senate Bill 2370, focusing on germaneness, data use, confidentiality and enforcement; no final action was taken and members asked for more study and another meeting.
A conference committee considering Senate Bill 2370 met to review proposed state reporting requirements related to the federal 340B drug discount program and its transparency, and members raised questions about whether the bill is germane to the vehicle, whether the state will gain useful information, and how confidentiality and civil penalties would be handled.
The committee spent the session examining whether adding reporting language tied to 340B to SB 2370 is appropriate and effective. Several members said hospitals already report detailed 340B information to the federal Health Resources and Services Administration (HRSA), and that pharmacy benefit managers and drug manufacturers have successfully withheld proprietary data from state requests in…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
